TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.220nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 86nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 206nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair
Affinity DataKi: 600nMAssay Description:Inhibition of Rattus norvegicus (rat) liver cytosolic CK2More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 1.47E+3nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair